RCM
BSX icon

Reynolds Capital Management’s Boston Scientific BSX Stock Holding History

Reynolds Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-11,200
Closed -$199K – 217
2015
Q1 		$199K Buy
+11,200
New +$177K 0.17% 231
2014
Q2 		– Sell
-27,000
Closed -$365K – 346
2014
Q1 		$365K Buy
27,000
+3,700
+16% +$48.6K 0.24% 159
2013
Q4 		$280K Hold
23,300
– – 0.16% 257
2013
Q3 		$274K Buy
23,300
+4,000
+21% +$43.3K 0.18% 242
2013
Q2 		$179K Buy
+19,300
New +$164K 0.13% 328

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Reynolds Capital Management's BSX Position: Q2 2015 in Review

Reynolds Capital Management sold out of Boston Scientific (BSX) in Q2 2015, closing a stake of 11,200 shares — an estimated $199K sold.

Reynolds Capital Management first reported a position in BSX in Q2 2013 and held it in 5 quarters. The position peaked at $365K in Q1 2014. 471 funds tracked by Wall St. Rank hold BSX as of Q2 2015.

  • Reynolds Capital Management reported no remaining Boston Scientific position as of Q2 2015 after selling out during the quarter.
  • Reynolds Capital Management sold 11,200 Boston Scientific shares in Q2 2015, an estimated $199K.
  • Reynolds Capital Management first reported a position in Boston Scientific in Q2 2013 and held it in 5 quarters.
  • Reynolds Capital Management's Boston Scientific position peaked at $365K in Q1 2014.
  • 471 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2015.

Based on Reynolds Capital Management's 13F filing for Q2 2015, filed 12 Aug 2015.